نتایج جستجو برای: nafld fiibrosis score

تعداد نتایج: 225767  

2014
Ali Jafarian Amirpasha Ebrahimi Farid Azmoudeh Ardalan Habibollah Dashti Mojgan Rahimi Mandana Salehi Mohsen Nasiri Toosi

BACKGROUND Liver transplantation is a critical survival point for patients with end stage liver diseases. It can dramatically increase patients' survival if the donor liver is intact. One aspect of liver health is absence of steatosis. Nonalcoholic Steato Hepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD) are increasing among young adults and patients living with chronic liver diseas...

Journal: :hepatitis monthly 0
mohsen razavizade internal medicine ward, shahid beheshti kashan hospital, kashan university of medical sciences, kashan, ir iran raika jamali research development center, sina hospital, tehran university of medical sciences, tehran, ir iran; students scientific research center, tehran university of medical sciences, tehran, ir iran; students scientific research center, research development center, sina hospital, tehran university of medical sciences, tehran, ir iran. tel: +98-2163120000, fax: +98-2163120001 abbas arj internal medicine ward, shahid beheshti kashan hospital, kashan university of medical sciences, kashan, ir iran seyyed mohammad matini internal medicine ward, shahid beheshti kashan hospital, kashan university of medical sciences, kashan, ir iran alireza moraveji department of community medicine, kashan university of medical sciences, kashan, ir iran effat taherkhani internal medicine ward, shahid beheshti kashan hospital, kashan university of medical sciences, kashan, ir iran

background non-alcoholic fatty liver disease (nafld) is considered as the hepatic manifestation of insulin resistance (ir) syndrome. the effect of insulin sensitizers on liver function tests and metabolic indices in nafld patients is a matter of debate. objectives the aim of study was to compare the effects of two different insulin sensitizers, pioglitazone, and metformin, on liver function tes...

Journal: :Metabolism and target organ damage 2023

Liver fibrosis is critical for liver-related outcomes and mortality in chronic liver disease, irrespective of etiology, including nonalcoholic fatty disease (NAFLD). NAFLD has been viewed as an independent correlate cardiovascular risk. This review article briefly describes the cellular molecular pathomechanisms underlying hepatic fibrosis. We then address noninvasive assessment Finally, we dis...

2017
Mark CC Cheah Arthur J McCullough George Boon-Bee Goh

Non-alcoholic fatty liver disease (NAFLD) is a burgeoning global health concern. In the subset of NAFLD patients with non-alcoholic steatohepatitis (NASH), the presence of significant fibrosis at index assessment is associated with poor prognosis and increased mortality. Hence, there is a growing need to accurately assess and stage fibrosis. Liver biopsy, the current gold standard, has limitati...

Journal: :Hepatitis Monthly 2022

Background: The present study aimed to investigate the relationship of non-alcoholic fatty liver disease (NAFLD) with severity and extent coronary stenotic lesions calculated by Gensini score. In addition, ability Fibrosis-4 (FIB4) score differentiate artery calcification (CAC) its is assessed. Methods: current retrospective was performed on a total 342 patients examined between January Decembe...

Journal: :PloS one 2015
Golnar Karimian Marc Kirschbaum Zwanida J Veldhuis Fernanda Bomfati Robert J Porte Ton Lisman

BACKGROUND AND AIM The progression of non-alcoholic fatty liver disease (NAFLD) likely involves a 'multiple hit' mechanism. We hypothesized that partial hepatectomy, a procedure performed frequently in patients with NAFLD, would accelerate the progression of disease. METHODS C57BL/6JolaHsd mice were fed a choline-deficient L-amino acid-defined diet (CD-AA) or a choline-sufficient L-amino acid...

2014
Arnold von Eckardstein

Owing to the high prevalence and associated complications of liver fibrosis, of any etiology, and nonalcoholic fatty liver disease (NAFLD), both have become important public health issues. Liver biopsy is considered the gold standard for diagnosis and staging of liver fibrosis, as well as NAFLD. Recent studies have discovered and validated several non-invasive biochemical biomarkers and imaging...

2016
Jae Hwa Jung Mo Kyung Jung Ki Eun Kim Ah Reum Kwon Hyun Wook Chae Choon Sik Yoon Ho Seong Kim Duk-Hee Kim

PURPOSE Abdominal obesity is a fundamental factor underlying the development of metabolic syndrome. Because of radiation exposure and cost, computed tomography or dual-energy X-ray absorptiometry to evaluate abdominal adiposity are not appropriate in children. Authors evaluated whether ultrasound results could be an indicator of insulin resistance and nonalcoholic fatty liver disease (NAFLD). ...

Journal: :Asian Journal of Medical Sciences 2023

Background: Non-alcoholic fatty liver disease (NAFLD) and diabetes are two common health problems of global concern. Diabetic nephropathy (DN) is also a microvascular complication diabetes. However, there little knowledge about the relationship between NAFLD DN. Aims Objectives: The aim this study was to know association DN in type 2 mellitus (T2DM) patients. Materials Methods: A cross-sectiona...

2014
Juliana Maya Monteiro Geysa Maya Monteiro Adriana Caroli-Bottino Vera Lucia Pannain

The morphological features of nonalcoholic fatty liver disease (NAFLD) range from steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Liver biopsy remains the main tool for NASH diagnosis and many histological systems to diagnose and grade NAFLD were proposed. We evaluated the relationship among NAFLD activity score (NAS), histological diagnoses (non-NASH, possible NASH, and definit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید